HuGE Literature Finder
Records 1-3
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
Leukemia & lymphoma 2017 12 58 (12): 2880-2894. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin.
Oncology research 2012 20 (1): 1. Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE |
Gemcitabine pathway genotype analysis to predict toxicity in phase II gemcitabine monotherapy in heavily pre-treated metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jul 22 (14_suppl): 2066. Chung H C, Rha S Y, Jeung H, Choi Y, Park K, Sohn J, Kim C, Kim G E, Yoo J H, Kim Y |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 15, 2021
- Content source: